Woodstock Corp’s GoodRx Holdings GDRX Stock Holding History

Woodstock Corp’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-102,029	Closed	-$294K	–	162
2026 Q2	$294K	Hold	102,029	–	–	0.02%	139
2026 Q1	$200K	Hold	102,029	–	–	0.02%	150
2025 Q4	$276K	Buy	+102,029	New	+$335K	0.02%	144

Other funds holding GDRX

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

LWM

Lodestone Wealth Management Spokane, Washington $297M AUM 25.27% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

ATC

Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return

Woodstock Corp's GDRX Position: Q3 2026 in Review

Woodstock Corp sold out of GoodRx Holdings (GDRX) in Q3 2026, closing a stake of 102,029 shares — an estimated $294K sold.

Woodstock Corp first reported a position in GDRX in Q4 2025 and held it in 3 quarters. The position peaked at $294K in Q2 2026. 8 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

Woodstock Corp reported no remaining GoodRx Holdings position as of Q3 2026 after selling out during the quarter.
Woodstock Corp sold 102,029 GoodRx Holdings shares in Q3 2026, an estimated $294K.
Woodstock Corp first reported a position in GoodRx Holdings in Q4 2025 and held it in 3 quarters.
Woodstock Corp's GoodRx Holdings position peaked at $294K in Q2 2026.
8 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on Woodstock Corp's 13F filing for Q3 2026, filed 13 Oct 2026.